Jasper Therapeutics holds annual stockholders meeting; 75% of shares represented

Reuters2026/08/03 20:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Jasper Therapeutics held its annual shareholder meeting on July 31, 2026.
Shareholders selected two Class II directors to serve until the 2029 annual meeting.
PwC’s appointment as independent registered public accounting firm for fiscal 2026 was ratified.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-084687), on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Jasper Therapeutics holds annual stockholders meeting; 75% of shares represented

You may also like

Crypto prices